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Abstract 
Homeobox (HOX) genes are conserved transcription factors which determine the anterior-
posterior body axis patterning. HOXD8 is a member of HOX genes deregulated in several 
tumors such as lung carcinoma, neuroblastoma, glioma and colorectal cancer (CRC) in a 
context-dependent manner. In CRC, HOXD8 is downregulated in cancer tissues and metastatic 
foci as compared to normal tissues. Whether HOXD8 acts as a tumor suppressor of malignant 
progression and metastasis is still unclear. Also, the underlying mechanism of its function 
including the downstream targets is totally unknown. Here, we clarified the lower expression of 
HOXD8 in clinical colorectal cancer vs. normal colon tissues. Also, we showed that stable 
expression of HOXD8 in colorectal cancer cells significantly reduced the cell proliferation, 
anchorage-independent growth and invasion. Further, using The Cancer Genome Atlas (TCGA), 
we identified the genes associated with HOXD8 in order to demonstrate its function as a 
suppressor or a promoter of colorectal carcinoma. Among inversely related genes, apoptotic 
inhibitors like STK38 kinase and MYC were shown to be negatively associated with HOXD8. 
We demonstrated the ability of HOXD8 to upregulate executioner caspases 6 & 7 and cleaved 
PARP, thus inducing the apoptotic events in colorectal cancer cells.  
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
The homeobox (HOX) genes are developmental regulatory genes which give cells positional 
information in embryogenesis [1]. There is a common sequence element of 180 bp encoding for 
highly conserved 60-amino-acid homeodomain called the homeobox. This binding ability of HOX 
genes to DNA is conferred by the homeodomain to act as transcription factors (TF) [2]. HOXA, 
HOXB, HOXC and HOXD, found on separate chromosomes are forming the four gene clusters of 
39 HOX genes in mammals [3]. In a highly coordinated manner, the HOX genes are expressed 
spatio-temporally during emryogenesis to build up regional identities along the anterior-
posterior body axis [4]. The role of HOX genes to regulate the differentiation or maturation in 
organs and tissues is not exclusive to the embryo. It has recently become apparent that the 
patterns of expression of HOX genes are organ- or tissue characteristic not only in the embryo 
but also in the adult or post-natal body [5]. Furthermore, aberrant expression of particular HOX 
genes has been reported in several types of carcinomas suggesting that HOX genes are involved 
in oncogenesis and malignant progression [6]. For instance, expression of 39 HOX genes was 
deregulated in lung, breast, oral and esophageal cancers and melanoma [7-11]. Other reports also 
showed differences in expression patterns of HOX genes in cancers of kidney, colon, prostate, 
and uterus [12-15].      
Nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) constitute the HOXD cluster and are 
positioned sequentially from 3' to 5', with HOXD1 at the 3' end and HOXD13 at the 5' end. 
Among HOXD cluster, induction of HOXD8, HOXD9, HOXD10 or HOXD12 induces growth 
arrest and neuronal differentiation with downregulation of cell cycle-promoting genes and 
upregulation of differentiation genes [16]. Nevertheless, other HOXD genes like HOXD1, HOXD3, 
HOXD4, HOXD11 and HOXD13 have no or partial effects on neuroblastoma cell proliferation or 
differentiation [16]. These findings highlight the distinct functions of HOXD genes in the 
induction of cancer cell differentiation.  
In colorectal cancer (CRC), HOXD8 expression was downregulated in clinical cancer tissues 
especially in metastatic foci as compared to primary tissues [1]. Also, HOXD8 is among the 
downstream restricted targets of miR-196a which has a potential oncogenic function in 
colorectal cancer. Depletion of HOXD8 mRNA levels by miR-196a in colorectal cancer results in 
inhibition of differentiation and promotion of oncogenic features [17]. In this sense, lowered 
expression of HOXD8 in colorectal cancer tissues fascinated us to understand the role of 
HOXD8 in CRC and explain whether HOXD8 may act as a tumor suppressor of malignant 
progression and metastasis. 
In the current study, we demonstrated that HOXD8 expression suppresses colorectal cancer cell 
proliferation, colony forming capacity and invasion. TCGA analysis showed that HOXD8 is 
negatively associated with STK38 and MYC which have a negative impact on apoptotic 
pathways rendering infinite cancer cell growth. Stable expression of HOXD8 downregulated the 
expression of MYC mRNA and upregulated the apoptotic marker proteins. Our results uncover 
for the first time, the relationship between HOXD8, STK38 and MYC in apoptosis of cancer cells. 
Further studies are warranted to elucidate the mechanistic insights of this association and to 
uncover more downstream targets of HOXD8 in CRC and other types of cancer.  
2. Materials and Methods 
2.1. Culture cells and antibodies  
Colorectal cancer cells, HCT116, DLD-1 and HT29 cells, were obtained from American Type 
Culture Collection (ATCC) and cultured in DMEM (for HCT116 and HT29) or RPMI (for DLD-1) 
supplemented with 10% fetal bovine serum (FBS) (EQUITEC, Hen-dra, Australia). We 
authenticated the cancer cells by short tandem repeat analysis using gene print®10 system 
(Promega,Madison, WI). The antibodies used were purchased from the following manufacturers: 
anti-E-cadherin antibody, BD Biosciences (San Jose, CA); anti-β-actin antibody, Sigma-Aldrich, 
St. Louis,MO, USA; anti-GFP antibody, Neuro Mab (Davis,CA); anti-palladin, as previously 
produced [18,19]; anti-cleaved caspase-6 (Asp162), anti-cleaved caspase-7 (Asp198), anti-cleaved 
PARP (Asp214), anti-phospho-ERK1/2 and anti-phospho-AKT (Ser473) antibodies, cell signaling 
technology®, Danvers, MA, USA. 
2.2. Patients and ethical statement 
Normal and colorectal cancer patients who went through surgery at Nagoya University 
graduate school of Medicine hospital were participating in this study. For the detection of 
HOXD8 mRNA expression levels in normal vs. colorectal cancer specimens (stages II-IV 
collected from male and female patients (Age 30-60 yr).), qRT-PCR analysis was performed. 
Written informed consents were provided from the participating patients and the study plan 
was approved by the institutional review board of the university as conformed to the standards 
set by the Declaration of Helsinki. 
 2.3. qRT-PCR (Quantitative Real-Time PCR) 
Endogenous mRNA from normal colon and colorectal cancer samples was extracted using the 
RNeasy mini kit (Qiagen, Venlo, Netherlands), and then the corresponding cDNAs were 
synthesized using primescript Reverse Transcriptase (TAKARA, Tokyo, Japan). The normal 
colon and colorectal cancer tissues were obtained from patients who underwent surgery at the 
Nagoya University Hospital. The real time PCR was performed using the SYBR Premix Ex 
TaqTM II (TAKARTA), and the Thermal Cycler Dice TM Real Time System TP800 (TAKARA) was 
utilized for the analysis and quantification of the gene expression. The relative mRNA level of 
each gene was normalized to GAPDH. The sequences of primers used to amplify each gene were 
5´-AGGTGGAGGAGTGGGTGTCGCTGTT-3´ and 5´-CCGGGAAACTGTGGCGTGATGG-3´ 
(GAPDH), 5´-GTTTTGAACCGCCCTTGTAA-3´ and 5´-GTGAGGCTATCGCTTTCCTG-3´ 
(HOXD8), and 5’-CATCAGCACAACTACGCAGC-3’ and 5’-GCTGGTGCATTTTCGGTTGT-3’ 
(MYC). 
2.4. Analysis of Oncomine data 
To determine the expression pattern of HOXD8 in colorectal cancer, the datasets in Oncomine, a 
cancer microarray database (https://www.oncomine.org), were utilized. In brief, HOXD8 gene 
was queried in the database and the results were filtered by selecting colorectal cancer and 
Colon Cancer vs. Normal Analysis. The data was displayed by using Column chart. P-values for 
each group were calculated using student t-test. Other details of standardized normalization 
techniques and statistical calculations can be found on the Oncomine. 
2.5. cDNA constructs 
Complementary DNA (cDNA) for the human gene; HOXD8 was amplified by Polymerase Chain 
Reaction (PCR) from a cDNA library of HeLa cells. A cDNA library simply contains sequences 
that are complementary to mRNAs transcribed from the human genome. The cDNA was then 
cloned into the pQCXIP vector (TAKATA, Tokyo, Japan) with an N-terminal green fluorescence 
protein (GFP) tag as described previously [20]. Hence, GFP or GFP HOXD8 clones were ready for 
retroviral infection into the cancer cells. 
 
2.6. Establishment of stable cell lines 
Colorectal cancer cells, HCT116, DLD-1 and HT29 that constitutively expressed GFP and GFP 
HOXD8 were generated by retrovirus infection. The pQCXIP vector encoding GFP or GFP 
HOXD8 was transfected into the human embryonic kidney (HEK) 293 cells in combination with 
the pVPack-GP and pVPack-Ampho vectors (Stratagene, Tokyo, Japan) using Lipofectamine 
3000 (Invitrogen, Carlsbad, CA). After 48 h transfection, the collected supernatants were added 
to HCT116, DLD-1 or HT29 cells with 2 μg/mL polybrene (Sigma-Aldrich, St. Louis, MO, USA), 
and infected cells expressing each vector were selected with 1 μg/mL puromycin (Sigma-Aldrich, 
St. Louis, MO, USA) for three constitutive days as described previously [21].  
2.7. Western blot analysis  
Western blotting analysis was conducted as described previously [22]. The cellular protein 
lysates cultured with GFP or GFP HOXD8 were prepared by incubating the cells with 2X 
sample buffer (1M Tris-HCl (pH 6.8), SDS, Glycerol, BPB (bromophenol blue, 2-
Mercaptoethanol) for 5 min at 100°C then were kept on ice till use. The Lowry protein assay 
(Thermal Scientific) was used to determine the protein concentration in each sample. Fifteen to 
twenty micrograms of the total protein from each sample were used for SDS-polyacrylamide gel 
electrophoresis (PAGE) and transferred to a polyvinylidene difluoride (PVDF) membranes 
(Millipore, Billerica, MA, USA) electrophoretically. In order to block nonspecific binding to 
proteins, the membranes were incubated in phosphate buffered saline containing 1% non-fat 
skim milk for 1 h at room temperature. Then, primary antibody was properly diluted and 
incubated with the membrane at 4˚C overnight. The membranes were then washed with TBS-T 
buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% Tween 20) for 10 min 3 constitutive times 
and incubated with HRP-labeled secondary antibodies for 1 h. Finally, the membranes were 
washed with TBS-T buffer for 10 min three times. The protein bands' signals were detected with 
the ECL system (Nacalai tesque, Kyoto, Japan). The signals' intensities were detected using 
Light Capture II equipped with CS analyzer (ATTO Corp., Tokyo, Japan). 
2.8. MTT cell proliferation assay 
The MTT cell proliferation assay is a colorimetric assay for assessing the proliferation rate of 
the cells. The assay depends on the activity of NADPH-dependent cellular oxidoreductase 
enzymes which reflect the number of viable cells. These enzymes are able to reduce the 
tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to its 
insoluble form, formazan, forming a purple color indicative of the number of cells present. The 
cells were infected with retrovirus for constitutive expression of GFP or GFP HOXD8 and 
cultured in 96-well plates. Then, after establishment of the stable cell lines, MTT assay was 
conducted from day 0, and the number of the cells at the indicated time points were estimated 
using the Cell Count Kit-8 (Dojindo, Tokyo, Japan) as described previously [23].  
2.9. Colony formation assay 
The colony forming capacity or anchorage-independent growth assay was performed as 
described previously [24]. Briefly, HCT116, DLD-1, HT29 cells (1 x 104) were cultured with 0.36% 
agar in 10% FBS DMEM and overlaid onto a 0.72% agarose layer in 6-well plates. After 2 weeks 
of incubation at 37°C, growing colonies in five randomly selected fields were counted. Three 
independent experiments were performed to assure the validity of the results and the data are 
shown as the mean ± SE. 
2.10. Cancer cell invasion assay 
To assess the cancer cell invasiveness using Boyden chambers, a filter (8-µm pore size, 6.5-mm 
membrane diameter) was pre-coated with matrigel overnight. Then, 2 x 105 HCT116 cells or 2 x 
104 DLD-1 cells were seeded onto the upper surface of the chamber with DMEM and 0.1% BSA 
(starvation) while the lower chamber was filled with DMEM and 10% FBS (chemo-attractant). 
After 24 h incubation at 37°C, the cells were fixed with 70% methanol and stained with 0.5% 
crystal violet. The cells which invaded the lower surface of the filters were counted in 5 
randomly selected fields as described previously [25]. Three independent experiments were 
performed. 
2.11. Homology modeling by the server SWISS-MODEL 
The server searches for the template with Blast and HHBlits against the SWISS-MODEL 
template library and the templates with the highest quality have been chosen for model 
building. Models are built based on the target (HOXD8)-template alignment using ProMod3. 
Coordinates conserved between the target and the template are copied from the template to the 
model. The geometry of the resulting model is regularized by using a force field. Also, homo-
oligomeric structure of the target protein (HOXD8) is predicted based on the analysis of 
pairwise interfaces of the identified template structures. More details of the model building, 
model quality estimation, ligand modeling, oligomeric state conservation can be found on the 
server Swiss-model. 
2.12. TUNEL assay 
The Terminal DNA transferase-mediated dUTP nick end labeling (TUNEL) assay was 
performed to determine in situ apoptotic DNA breaks by using the detection kit (Roche, Basel, 
Switzerland) according to the manufacturer's protocol. HCT116, DLD-1 and HT29 cells 
expressing FLAG or FLAG HOXD8 were established by retroviral infection. Cells attached to 
glass slides in culture dishes were subjected to the assay, imaged with fluorescence microscopy, 
and the percentage of TUNEL-positive cells was evaluated. 
2.13. Statistical analysis  
All data presented are as the mean ± Standard Error (SE). Statistical analysis for cancer cell 
proliferation, and colony forming capacity was performed by unpaired t-test using Microsoft 
Office Excel 2013. P values of <0.05 were considered statistically significant.  
3. Results 
3.1 HOXD8 mRNA is reduced in clinical colon cancer samples and HOXD8 expression 
reduces cancer cell proliferation in vitro 
In order to unravel the function of the homeobox D8 in colorectal cancer, we first examined 
HOXD8 mRNA levels in human normal colon and colorectal cancer specimens by qRT-PCR 
analysis. The analysis revealed a significant reduction in mRNA levels of HOXD8 in 18 human 
colorectal cancer tissues with 9 samples showing more than 5-fold decreases in HOXD8 mRNA 
compared with the normal controls (Fig. 1A). In parallel, we analyzed seven independent 
datasets from Oncomine database. The results showed that HOXD8 mRNA was differentially 
expressed in colon carcinoma in comparison to normal lung tissues. Among 40 samples, HOXD8 
expression in Skrzypczak Colorectal 2 dataset showed around 8-fold reduction in colon cancer as 
compared to the normal colon (Fig. 1B). These observations suggested that HOXD8 expression 
was reduced in colon cancer tissues. We next examined the expression level of HOXD8 in 
various colorectal cancer cell lines. qRT-PCR analysis showed that HOXD8 was expressed 
relatively high in SW620 and SW1080 cancer cells while expressed relatively low in HT29, 
DLD-1 and HCT116 cells (Fig. 1C). 
Then, we examined the effects of the exogenous expression of HOXD8 on colorectal cancer cells 
showing comparably lower expression of HOXD8. We established HCT116, DLD-1 and HT29 
cells that constitutively expressed GFP or GFP HOXD8 by retrovirus infection. The level of 
exogenously expressed GFP or GFP HOXD8 was identified by antibody against GFP tag (Fig. 
1D). To determine whether HOXD8 expression had any effect on cancer cell proliferation in 
vitro, we performed a cell proliferation assay. As shown in Fig. 1E, ectopic expression of HOXD8 
had a suppressive function on the proliferation of HCT116, DLD-1 and HT29 cells. In order to 
further assess the proliferative capacity of the cells with respect to apoptosis, we employed the 
Terminal DNA transferase-mediated dUTP nick end labeling (TUNEL) assay. After imaging the 
cells under fluorescence microscope, HOXD8 expression in HCT116, DLD-1 and HT29 cells 
significantly increased the percentage of in situ apoptotic DNA breaks indicating induction of 
apoptosis and suppression of cell proliferation (Supplementary Fig. 1A). 
The capability of cancer cells to exhibit anchorage-independent cell growth (colony formation 
capacity in semisolid media), has been considered to be a fundamental process in cancer biology. 
This is because it has been associated with cancer cell aggressiveness in vivo such as 
tumorigenic and metastatic potentials, and also used as a marker for in vitro cancer 
transformation. To explore whether HOXD8 expression inhibits the anchorage-independent 
growth of colorectal cancer cells, HOXD8-expressing cells were cultured in soft agar. After two 
weeks, the number of colonies and average colony size were determined. The results showed a 
significant suppression of the growth of HOXD8-expressng cells in the absence of cell adhesion 
to the extracellular matrix (Fig. 2A, 2B and 2C). These results show that HOXD8 has a 
suppressive effect on cancer cell proliferation and colony forming capacity.  
3.2 Exogenous expression of HOXD8 inhibits cancer cell invasion 
Cancer cell invasiveness and metastatic ability is a multistep process that comprises cell 
adherence modulation, extracellular matrix degradation, migration and proliferation at a 
secondary site; finally, tumor cells must also stimulate angiogenesis to attain increased growth 
requirements. Therefore, it is very important to measure the invasive ability of cancer cells to 
assess the tumor suppression character of certain genes. The Matrigel 'chemoinvasion' assay is 
a useful tool for this purpose and for screening of anti-invasive agents. One major simplification 
of this assay is the use of a reconstituted membrane 'Matrigel', which when applied in the 
Boyden chamber, cancer cell invasive potential can be rapidly quantified. This in vitro invasion 
assay was found to correspond to metastatic potential in vivo [26]. 
To evaluate cell invasion in HOXD8 expressing cells, we first observed the morphology of 
several colorectal cancer cells upon constitutive expression of HOXD8. As shown in Fig. 3A, 
HOXD8 expression rendered the cells more spherical in shape rather than fibroblastic 
(fibroblast-like) cells which are bipolar or multipolar, have elongated shapes, and grow attached 
to a cell surface substrate. Next, we used Matrigel-coated Boyden chambers and wild type (WT) 
DLD-1 cells and those expressing either GFP or GFP HOXD8 were seeded in the upper chamber, 
and invading cells were counted 24 h later in the lower surface. A significant reduction in 
invading cells was observed with HOXD8 expression as shown in Fig. 3B. 
3.3 Homology Modelling of HOXD8 
So far, we showed the function of HOXD8 in colorectal cancer cells to suppress the cancer cells' 
proliferation, colony formation and invasion. Due to the lack of 3-dimensional structure of 
HOXD8 in literature, we used the server SWISS-MODEL to theoretically expect the more likely 
structure of HOXD8. The SWISS-MODEL template library (SMTL version 2017-01-06, PDB 
release 2016-12-30) was searched with Blast [27] and HHBlits [28-31] for evolutionary similar 
structures which match the target sequence of HOXD8. The template protein was found to be 
2r5z.1.C which is a homeotic protein Sex combs reduced with 65.79 sequence identity and 0.51 
sequence similarity (Fig. 4A and 4B). The HOXD8 has N-terminus residues spanning around 
290 amino acids that through our analysis, the software predicted formation of three helices 
after comparing 181-256 amino acids residues with the template protein (Fig. 4C and 4D). But, 
the remaining residues contain abnormally abundant poly-A and poly-P that hindered the 
formation of any stable ternary structure. 
3.4 HOXD8 expression downregulates palladin and upregulates E-cadherin 
Due to the observed role of HOXD8 to suppress cancer cell invasiveness and modulate the 
fibroblast like cells to spherical shape, we checked the expression of palladin and E-cadherin in 
HOXD8 expressing cells. Palladin (PALLD) is an actin-associated protein with 9 isoforms as 
showed by the Universal Protein Database. Several reports including our recent study [19] have 
revealed that palladin is associated with malignant characteristics of multiple malignancies 
including colorectal cancer. Here, we examined palladin expression in HOXD8 expressing cells. 
We generated either GFP or GFP HOXD8 expressing HCT116 and DLD-1 cells by retrovirus 
infection. As shown in Fig. 5A, immunoblot analysis showed that HOXD8 expression inhibited 
palladin isoforms (115 & 140 kDa) in HCT116, however, DLD-1 cells did not show the 
expression of palladin. On the other hand, the epithelial cadherin (E-cadherin) has been 
implicated in tumor suppression and cellular adherence within a tissue, resulting in a decrease 
in cellular motility. In the current study, HOXD8 expression upregulated E-cadherin level in 
HCT116 and DLD-1 cells as compared to GFP only cells (Fig. 5A). As shown in Fig. 5B, we 
quantified these changes in the expression levels of palladin and E-cadherin by ImageJ analysis 
software. However, the phosphorylation of other signaling proteins, such as ERK1/2 and AKT, 
was not affected by HOXD8 expression (Figure 5A). 
3.5 TCGA indicates that HOXD8 is inversely correlated with STK38 and MYC 
To further dissect the tumor suppressing function of HOXD8, we performed The Cancer 
Genome Atlas (TCGA, Provisional) profiling of the genes significantly correlated with HOXD8 
in human colorectal cancer patients' datasets. Among 30 genes positively correlated with 
HOXD8, ZNF618 (Zinc Finger Protein 618), FOXD4 (Forkhead Box D4), ETV5 (ETS Variant 5), 
LMCD1 (LIM And Cysteine Rich Domains 1) and ZDBF2 (Zinc Finger DBF-Type Containing 2) 
have been identified with transcription factor activity and sequence-specific DNA binding 
according to gene ontology (GO) annotations (Table 1). These structural homologs are sequence-
specific transcription factors involved in developmental regulatory system to provide cells with 
specific positional identities on the anterior-posterior axis.  
On the other hand, among 6 inversely correlated genes with HOXD8, STK38 (Serine/Threonine 
Kinase 38) and the well-known oncoprotein MYC have been identified by TCGA analysis (Table 
2). Moreover, the dataset from TCGA database was analyzed to examine the correlation 
between HOXD8 and, STK38 and MYC at mRNA level in clinical colorectal cancer specimens by 
the cBioPortal platform. As shown in Fig. 6A and 6B, the correlation analysis in TCGA database 
showed that HOXD8 was inversely correlated with STK38 (Pearson: -0.31, Spearman: -0.39, 
N=382) and MYC (Pearson: -0.124, Spearman: -0.144, N=382). However, a correlation analysis 
in TCGA dataset showed that STK38 was positively correlated with MYC (Pearson: 0.133, 
Spearman: 0.166, N=382) (Fig. 6C). To confirm the negative association between HOXD8 and 
MYC, we used qRT-PCR analysis to check the expression of MYC mRNA levels in either GFP or 
GFP HOXD8. As shown in Fig. 6D, exogenous expression of HOXD8 in HCT116, DLD-1 and 
HT29 cells downregulated MYC mRNA levels as compared to GFP only cells. 
3.6 Expression of HOXD8 augments apoptosis of colorectal cancer cells 
Serine-threonine kinase 38, STK38/NDR1 has been shown to be a potential "druggable" target 
in several pathologies in which autophagy is critically involved [32]. Moreover, depletion of 
STK38 suppresses growth of MYC-addicted tumors by decreasing MYC levels and increasing 
apoptosis, thus we checked the expression of apoptotic markers in HOXD8 expressing cells. As 
shown in Fig. 7A, HOXD8 expression upregulated the executioner caspases 6 and 7 in HCT116 
and DLD-1 cells. Also, expression of HOXD8 increased the apoptotic marker cleaved poly (ADP-
ribose) polymerase (PARP) in both HCT116 and DLD-1 cells. We quantified the western blots 
using ImageJ analysis (Fig. 7B, 7C and 7D). Collectively, these findings clearly indicate the 
tumor suppressor function of HOXD8 via induction of apoptotic pathways in colorectal cancer 
cells. 
3.7 STRING database defines the functional interaction partners of HOXD8 
As an extension to the previous findings, we used the protein-protein interaction server, 
STRING, to define HOXD8 functional partners to further dissect its action in CRC. As shown in 
Supplementary Figure 2, among top three binding partners, prospero homeobox 1 (prospero 
homeobox 1) and homeobox D4 (HOXD4) were found to interact with HOXD8. 
4. Discussion 
Several HOX genes have been studied and shown to have specific roles in the development and 
invasion of several types of cancer cells. However, intensive understanding of the underlying 
molecular mechanisms including their transcriptional target genes, and co-factors or 
downstream effectors are still lacking. Our group previously demonstrated the significant 
contribution of several HOX genes to promote epithelial-to-mesenchymal transition (EMT) and 
invasion of cancer cells. For instance, the homeoproteins ALX1, ALX4 and HOXB13 were found 
to upregulate expression of the key EMT regulators and abrogate ovarian cancer cells’ invasion. 
[33,34]. Also, the paired related homeobox 1 (PRRX1) was associated with glioblastoma cell 
invasion [35]. An improved understanding of the mechanistic insights of these effects may reveal 
a means to create tailored, precision treatment of several malignancies. Meanwhile, the 
differential expression pattern of homeobox genes in various carcinomas may provide valuable 
information for cancer diagnosis of challenging cases of CRC. 
In the current report, we investigated the role of HOXD8 in colorectal cancer cells by gain of 
function strategy given its lower expression in CRC cells. Ectopic expression of HOXD8 
suppresses cancer cell proliferation, colony formation and cell invasiveness. Consistently, 
HOXD8 has previously been linked to differentiation process, whereas retinoic acid-induced 
differentiation of neuroblastoma upregulates a number of HOX genes including HOXD8 [36]. 
Also, individual induction of HOXD8 in neuroblastoma cells is sufficient to downregulate cell 
cycle-promoting genes and upregulate neuronal differentiation genes. However, depletion of 
HOXD8 significantly inhibits the retinoic acid-induced differentiation [16]. 
Low expression of HOXD8 is reported in several malignancies including pediatric brain tumors 
[37] and colorectal cancer [1]. In the latter type, HOXD8 expression levels were significantly lower 
in hepatic metastatic tissues than those in primary tissues proposing a metastasis suppressor 
function of HOXD8. Given the physiological function of HOXD8 to give the cells positional 
information in adult, it is thought that loss of HOXD8 may give the cancer cells misinformation 
to recognize the liver as an orthotopic organ. Hence, disturbance of positional information may 
render the tumor cells adapted to different micro-environment. Paradoxically, other reports [38, 
39] supported the overexpression of HOXD8 in non-small cell lung cancer to promote the cancer 
phenotype. Based on these findings, HOXD8 plays context-dependent functions in cancers given 
the nature of HOXD8 as a transcription factor targeting different downstream genes in each 
type of cancer.  
Regarding regulation of HOXD8 in cancer, genome-wide methylation analysis in mantle cell 
lymphoma [40] and glioblastoma [41] revealed a significant aberrancy in promoter methylation 
patterns compared with normal cells. Among hypermethylated genes, HOXD8 had an aberrant 
methylation pattern associated with inverse changes in mRNA levels. In colorectal cancer, 
several pro-oncogenic miRNAs promote the oncogenic phenotype of colorectal cancer cells. miR-
196a was reported to exert an oncogenic function in CRC by restricting the expression of 
HOXA7, HOXB8, HOXC8 and HOXD8 in a dose-dependent and gene-specific manner [17]. 
We elucidated the Serine-Threonine Kinase 38, STK38, which is a member of the highly 
conserved NDR kinase in mammalian cells [42], and MYC genes to be negatively associated with 
HOXD8. This negative association is proposed to be responsible for the induction of apoptotic 
events mediated by HOXD8 in cancer cells. Changes in STK38 expression has been correlated 
with carcinogenesis. Some reports suggest that overexpression of STK38 is associated with 
breast ductal carcinoma [43] and melanoma [44] progression. Conversely, in gastric cancer and B-
cell lymphoma, STK38 mRNA was downregulated as compared to normal tissues [45,46]. Hence, 
the role of STK38 in cancer progression appears to be context dependent. Bisikirska et al. [47] 
reported that knockdown of STK38 in vivo significantly suppresses B-cell lymphoma in a 
xenograft mouse model. It is thought that inactivation of STK38 activity reduces MYC protein 
expression and function, thus suppressing tumorigenesis mediated by MYC oncoprotein and 
increasing apoptosis. The oncogenic function of MYC is well-known in the etiology of most types 
of human cancers [48]. Overexpression of MYC oncoprotein elicits autonomous cell proliferation 
and fueling tumorigenesis [49]. Suppression of MYC activity is considered as a valuable 
therapeutic tool as inactivation of MYC would likely be associated with cytotoxicity given the 
physiological function of MYC in normal cells [47].   
Apoptosis or programmed cell death (PCD) is a cellular suicide program required to eliminate 
superfluous cells for tissue morphogenesis and emerging harmful cells like in case of cancer 
[50,51]. Although apoptosis is tightly controlled in normal cells, it is disrupted in cancer to 
promote infinite cell growth. Also, its regulation on the transcriptional level is less studied and 
understood [47]. Homeobox genes like HOXD8 are homeodomain transcription factors that have 
pivotal roles in development by eliciting several developmental programs along the anterior-
posterior axis. To this end, homeoproteins transcriptionally regulate cell-type specification, 
differentiation, proliferation and apoptosis in a highly coordinate manner. 
The interplay and regulatory wiring of differentiation and apoptosis are conserved in 
mammalian cells. For instance, CUT-like homeobox 1 (CUX1) activates the transcription of the 
proapoptotic gene puma [52] and has emerged as a tumor suppressor via interfering with PI3K 
signaling, a pathway known to control apoptosis [53]. Hence, it is very likely that the same 
regulatory interplay is used by homeobox transcription factors. This is because HOX genes are 
misregulated in cancer which is often associated with a deteriorated control of apoptotic 
pathways. 
In summary, we propose HOXD8 function to differentially shape tissues and control 
morphological outputs along the anterior-posterior axis by fine-tuning programmed cell death in 
healthy organisms. However, lower expression of this gene in CRC disrupts this homeostasis 
and inhibits apoptosis. Further investigations are required to uncover HOXD8 downstream 
genes and cofactors essential for target gene regulation and upstream regulators, which are 
often responsible for HOXD8 deregulation in various types of cancer. Also, the recent knowledge 
of the homeobox genes in colorectal cancer cancer could not achieve the clinical efficacy of 
therapeutic targets or biomarkers. Hence, it is required to be fulfilled in the future research. 
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Figure Legends 
Figure 1. HOXD8 is downregulated in clinical colorectal cancer tissues and HOXD8 expression 
reduces cancer cell proliferation. (A) The level of HOXD8 mRNA in colorectal cancer (n=18) and 
normal colorectal (n=3) tissues was evaluated by quantitative RT-PCR. The graph indicates the 
relative HOXD8 mRNA levels. (B) Analysis of the Oncomine colorectal adenocarcinoma 
database using colorectal cancer vs. normal colon datasets showing the relative expression of 
HOXD8 mRNA in clinical colorectal cancer specimens as compared to the normal colon. (C) The 
relative mRNA expression of HOXD8 normalized to glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH) mRNA in different colorectal cancer cell lines was examined by qRT-
PCR analysis. (D) HCT116 and DLD-1 cells constitutively expressing GFP or GFP HOXD8 were 
established by retrovirus infection. The expression of the indicated proteins (GFP, β-actin) in 
the cell lines was examined by immunoblotting. (E) HCT116, DLD-1 and HT29 cells were 
infected with either GFP or GFP HOXD8 vector by retroviral infection. The number of viable 
cells at the indicated time points was determined using a Cell Counting Kit-8 assay.  
 
Figure 2. HOXD8 reduces the colony forming capacity of several colorectal cancer cells. (A) 
HCT116 cells expressing either GFP or GFP HOXD8 were subjected to a colony formation assay. 
Representative images are shown, and the graphs indicate the average number (mean ± SE) 
and size (mean ± SE) of colonies per field (*P < 0.05). (B) DLD-1 cells expressing either GFP or 
GFP HOXD8 were subjected to a colony formation assay. Representative images are shown, and 
the graphs indicate the average number (mean ± SE) and size (mean ± SE) of colonies per field 
(*P < 0.05). (C) HT29 cells expressing either GFP or GFP HOXD8 were subjected to a colony 
formation assay. Representative images are shown, and the graphs indicate the average 
number (mean ± SE) and size (mean ± SE) of colonies per field (*P < 0.05). 
Figure 3. HOXD8 inhibits colorectal cancer cells invasion. (A) Representative images of the cell 
morphology and fluorescence (GFP) of HCT116, DLD-1 and HT29 cells expressing either GFP or 
GFP HOXD8; scale bar = 50 µm. The arrows show the apoptotic cells formed upon expression of 
HOXD8 (B) WT, GFP or GFP-SATB2 DLD-1 cells were subjected to a Boyden chamber invasion 
assay. Representative images of invaded DLD-1 cells are shown, and the graph indicates the 
average number (mean ± SE) of invaded cells per field (*P<0.05). 
 
 
Figure 4. Homology modeling and oligomeric state conservation of HOXD8. (A) Homology 
modeling analysis results indicating 2r5z.1.c as the most proper template for HOXD8 with 65.79 
sequence identity. (B) Model-template alignment by server Swiss-model. (C) The ribbon style of 
HOXD8 protein is shown with coil, helix and strand. (D) Hydrophobicity surface of HOXD8 
protein is shown with colors ranging from dodger blue for the most hydrophilic to white at 0.0 to 
orange red for the most hydrophobic.  
  
Figure 5. Expression of HOXD8 inhibits palladin (140 kDa) and upregulates E-cadherin in 
colorectal cancer cells. (A) HCT116 and DLD-1 cells constitutively expressing GFP or GFP 
HOXD8 were established by retrovirus infection and the expression of palladin and E-cadherin 
was checked by immunoblotting. Β-actin was used as a loading control for the western blot 
analysis. Arrows indicate the several isoforms of palladin (200, 140, 115, 90 & 50 kDa) (B) 
ImageJ analysis was used to quantify the signal intensities of western blots of palladin and E-
cadherin taking β-actin as the control protein. 
 
Figure 6. HOXD8 is negatively associated with STK38 and MYC genes. (A) Analysis of The 
Cancer Genome Atlas (TCGA) colorectal adenocarcinoma database (TCGA, Provisional) using 
cBioPortal showing the correlation between HOXD8 and STK38 mRNA levels. (B) The 
correlation analysis performed by TCGA to compare between HOXD8 and MYC mRNA levels. 
(C) The correlation analysis performed by TCGA to compare between STK38 and MYC mRNA 
levels. (D) The MYC mRNA expression level in HCT116, DLD-1 and HT29 cells either 
expressing GFP or GFP HOXD8 was analyzed by quantitative RT-PCR analysis. The graph 
indicates relative MYC mRNA level as normalized to GAPDH. 
 
Figure 7. Expression of HOXD8 increases executive caspases 6 &7 and cleaved-PARP. (A) 
HCT116 and DLD-1 cells constitutively expressing GFP or GFP HOXD8 were established by 
retrovirus infection. The expression of the indicated proteins (cleaved caspase 6, cleaved caspase 
7 and cleaved PARP) in the cell lines was examined by immunoblotting taking β-actin as the 
loading control. (B) ImageJ analysis was used to quantify the signal intensities of western blots 
of cleaved caspase 6 taking β-actin as the control protein. (C) ImageJ analysis was used to 
quantify the signal intensities of western blots of cleaved caspase 7 taking β-actin as the control 
protein. (D) ImageJ analysis was used to quantify the signal intensities of western blots of 
cleaved PARP taking β-actin as the control protein. 
 
 
Supplementary Figure 1. Expression of HOXD8 increases percentage of apoptotic cells. (A) Bar 
graph of the TUNEL-positive apoptotic cells in FLAG or FLAG HOXD8 cells. HCT116, DLD-1 
and HT29 cells constitutively expressing FLAG or FLAG HOXD8 were established by retrovirus 
infection. The percentage of apoptotic cells were assessed by the terminal deoxynucleotidyl 
transferase-mediated dUTP biotin nick-end labeling (TUNEL) assay using the In Situ Cell 
Death Detection.  
Supplementary Figure 2. Binding partners of HOXD8 as analyzed by STRING database. (A) 
The network nodes represent proteins that are found to interact with HOXD8. (B) The 
interacting proteins were tabulated with its respective gene name and score of interaction as 
predicted by STRING database. 
 
 
 
 
  
 
 
  
  
 
 
 
 
 
  
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 Table 1: Genetic profiling of the most significant positively correlated genes with HOXD8 performed by 
The Cancer Genome Atlas (TCGA, Provisional). 
Correlated gene 
Pearson's 
Correlation 
Spearman's 
Correlation Entrez Gene  
GeneCards  
ZNF618 (Zinc 
Finger Protein 
618) 
0.33 0.43 
Not available GO annotations connected 
to this gene: nucleic acid 
binding. 
FOXD4 
(Forkhead Box 
D4) 
0.35 0.32 
The gene plays 
crucial roles in the 
regulation of 
metabolism, cell 
proliferation and 
gene expression. 
GO annotations connected 
to this gene: transcription 
factor activity, sequence-
specific DNA binding and 
RNA polymerase II 
transcription factor 
activity. 
MTMR9 
(Myotubularin 
Related Protein 
9) 
0.32 0.37 
The encoded protein 
is thought to have a 
role in the control of 
cell proliferation. 
GO annotations  connected 
to this gene: phosphatase 
activity and enzyme 
regulator activity. 
RAET1K 
(Retinoic Acid 
Early Transcript 
1K Pseudogene) 
0.33 0.34 
Not available Pseudogene 
FYN (FYN Proto-
Oncogene, Src 
Family Tyrosine 
Kinase) 
0.31 0.39 
It is implicated in 
the control of cell 
growth. 
GO annotations  connected 
to this gene: transferase 
activity, transferring 
phosphorus-containing 
groups and protein 
tyrosine kinase activity. 
DBN1 (Drebrin 
1) 
0.35 0.39 
The  encoded protein 
is a cytoplasmic 
actin-binding 
protein.  
GO annotations  connected 
to this gene: actin binding 
and profilin binding. 
TXNDC15 
(Thioredoxin 
Domain 
Containing 15) 
0.34 0.39 
Not available Protein Coding gene. 
C5orf15 
(Chromosome 5 
Open Reading 
Frame 15) 
0.35 0.36 
Not available Protein Coding gene. 
SGTB (Small 
Glutamine Rich 
Tetratricopeptide 
Repeat 
Containing Beta) 
0.38 0.38 
Not available Protein Coding gene.  
SPRY1 (Sprouty 
RTK Signaling 
0.31 0.34 
Not available Protein Coding gene. 
Antagonist 1) 
ANXA5 (Annexin 
A5) 
0.34 0.40 
It is a phospholipase 
A2 and protein 
kinase C inhibitory 
protein. 
GO annotations  connected 
to this gene: calcium ion 
binding and calcium-
dependent phospholipid 
binding.  
ETV5 (ETS 
Variant 5) 
0.39 0.40 
Not available GO annotations  connected 
to this gene: transcription 
factor activity and 
sequence-specific DNA 
binding. 
USP13 
(Ubiquitin 
Specific 
Peptidase 13 
(Isopeptidase T-
3)) 
0.30 0.31 
Not available Among its related 
pathways are Ubiquitin-
Proteasome Dependent 
Proteolysis. 
WWTR1 (WW 
Domain 
Containing 
Transcription 
Regulator 1) 
0.33 0.42 
Not available GO annotations  connected 
to this gene: protein 
homodimerization activity 
and transcription 
corepressor activity. 
LMCD1 (LIM 
And Cysteine 
Rich Domains 1) 
0.37 0.46 
The encoded protein 
may act as a co-
regulator of 
transcription. 
GO annotations  connected 
to this gene: transcription 
corepressor activity. 
GNAI2 (G 
Protein Subunit 
Alpha I2) 
0.35 0.44 
It is involved in the 
hormonal regulation 
of adenylate cyclase.  
GO annotations  connected 
to this gene: GTP binding 
and signal transducer 
activity. 
ZDBF2 (Zinc 
Finger DBF-Type 
Containing 2) 
0.33 0.34 
The encoded protein 
contains DBF4-type 
zinc finger domains. 
GO annotations  connected 
to this gene: nucleic acid 
binding. 
CHN1 (Chimerin 
1) 
0.32 0.40 
It plays an 
important role in 
neuronal signal-
transduction  
GO annotations  connected 
to this gene: GTPase 
activator activity and 
ephrin receptor binding. 
HOXD1 
(Homeobox D1) 
0.41 0.55 
Transcription factor 
involved in 
differentiation and 
limb development.  
GO annotations  connected 
to this gene: sequence-
specific DNA binding. 
HOXD3 
(Homeobox D3) 
0.71 0.72 
It is a transcription 
factor that plays an 
important role in 
morphogenesis in all 
multicellular 
organisms. 
GO annotations  connected 
to this gene: transcription 
factor activity and 
sequence-specific DNA 
binding. 
HOXD4 
(Homeobox D4) 
0.69 0.74 
It plays an 
important role in 
morphogenesis in all 
GO annotations  connected 
to this gene: transcription 
factor activity and 
multicellular 
organisms. 
sequence-specific DNA 
binding. 
HOXD9 
(Homeobox D9) 
0.63 0.71 
It plays an 
important role in 
morphogenesis in all 
multicellular 
organisms.  
GO annotations  connected 
to this gene: transcription 
factor activity, sequence-
specific DNA binding and 
RNA polymerase II 
regulatory region 
sequence-specific DNA 
binding. 
HOXD10 
(Homeobox D10) 
0.48 0.41 
The encoded protein 
contains a homeobox 
DNA-binding 
domain.  
It is related to 
Proteoglycans in cancer 
and MicroRNAs in cancer. 
GO annotations  connected 
to this gene: transcription 
factor activity, sequence-
specific DNA binding and 
chromatin binding. 
HOXD11 
(Homeobox D11) 
0.50 0.42 
It plays an 
important role in 
morphogenesis in all 
multicellular 
organisms. 
GO annotations  connected 
to this gene: sequence-
specific DNA binding. 
HOXD13 
(Homeobox D13) 
0.42 0.35 
It plays an 
important role in 
morphogenesis in all 
multicellular 
organisms. 
GO annotations  connected 
to this gene: transcription 
factor activity, sequence-
specific DNA binding and 
chromatin binding. 
GPR155 (G 
Protein-Coupled 
Receptor 155) 
0.39 0.32 
Not available Protein Coding gene. 
 
MAP4K4 
(Mitogen-
Activated Protein 
Kinase Kinase 
Kinase Kinase 4) 
0.31 0.30 
It is a member of the 
serine/threonine 
protein kinase 
family. This kinase 
has been shown to 
specifically activate 
MAPK8/JNK.  
GO annotations  connected 
to this gene: transferase 
activity, transferring 
phosphorus-containing 
groups and protein 
tyrosine kinase activity. 
MAPK11 
(Mitogen-
Activated Protein 
Kinase 11) 
0.33 0.43 
It is involved in the 
integration of 
biochemical signals 
for a wide variety of 
cellular processes, 
including cell 
proliferation, 
differentiatio, and 
development. 
GO annotations  connected 
to this gene: transferase 
activity, transferring 
phosphorus-containing 
groups and protein 
tyrosine kinase activity. 
APOBEC3F 
(Apolipoprotein B 
MRNA Editing 
0.39 0.43 
It is a member of the 
cytidine deaminase 
gene family. 
GO annotations  connected 
to this gene: poly(A) RNA 
binding and hydrolase 
  
Table 2: Genetic profiling of the most significant negatively correlated genes with HOXD8 performed by 
The Cancer Genome Atlas (TCGA). 
 
Enzyme Catalytic 
Subunit 3F) 
activity, acting on carbon-
nitrogen (but not peptide) 
bonds, in cyclic amidines. 
APOBEC3D 
(Apolipoprotein B 
MRNA Editing 
Enzyme Catalytic 
Subunit 3D) 
0.31 0.38 
It is a member of the 
cytidine deaminase 
gene family. 
GO annotations  connected 
to this gene: hydrolase 
activity, acting on carbon-
nitrogen (but not peptide) 
bonds, in cyclic amidines. 
Correlated gene 
Pearson's 
Correlation 
Spearman's 
Correlation Entrez Gene  
GeneCards  
STK38 
(Serine/Threonine 
Kinase 38) 
-0.31 -0.39 
The encoded protein has 
been shown to function 
in the cell cycle and 
apoptosis. This protein 
has also been found to 
regulate the protein 
stability and 
transcriptional activity 
of the MYC oncogene.  
GO annotations connected 
to this gene: transferase 
activity, transferring 
phosphorus-containing 
groups and protein 
tyrosine kinase activity. 
GPD1L (Glycerol-
3-Phosphate 
Dehydrogenase 1-
Like) 
-0.36 -0.41 
The encoded protein is 
found in the cytoplasm, 
associated with the 
plasma membrane, 
where it binds the 
sodium channel, voltage-
gated, type V, alpha 
subunit (SCN5A). 
GO annotations  connected 
to this gene: protein 
homodimerization activity 
and NAD binding. 
LRRFIP2 (LRR 
Binding FLII 
Interacting 
Protein 2) 
-0.33 -0.36 
Not available GO annotations  connected 
to this gene: protein 
dimerization activity and 
LRR domain binding. 
FAM84A (Family 
With Sequence 
Similarity 84 
Member A 
-0.35 -0.38 
Not available Protein Coding gene. 
DOK4 (Docking 
Protein 4) 
-0.31 -0.34 
Not available GO annotations  connected 
to this gene: receptor 
signaling protein activity 
and insulin receptor 
binding. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
